Company / Operating Cash Flow per Share
RHYTHM PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.85
FY2025
5-year range
-$3.33 / -$1.85
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#143 of 212
Health Care
What the data says
At $-1.85, RHYTHM PHARMACEUTICALS, INC.'s operating cash flow per share ranks #143 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $-3.33 in FY2022 to $-1.85 in FY2025.
Based on SEC 10-K filings.
-1.85 in FY2025.
Improved from $-2.41 to $-1.85 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#143 of 212 in Health CareTop 67% of 212This company -$1.85 Sector average -$14.72
▼
+87.4% above sector average
Key checks
Key Insights
- RHYTHM PHARMACEUTICALS, INC.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 3.2% year-over-year.
- Ranks #143 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.85 | +3.2% |
| FY2024 | -$1.92 | +20.3% |
| FY2023 | -$2.41 | +27.7% |
| FY2022 | -$3.33 | -13.0% |
| FY2021 | -$2.94 | -6.5% |
| FY2020 | -$2.76 | +18.0% |
| FY2019 | -$3.37 | -48.2% |
| FY2018 | -$2.27 | +21.3% |
| FY2017 | -$2.89 | -26.9% |
| FY2016 | -$2.28 | -232.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026